Shortage Watch Free FDA drug-shortage watch

← all medications

Tranylcypromine Sulfate Tablet

Brand names: Tranylcypromine Sulfate

Category: Psychiatry

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Oct 21, 2025 · First posted: Oct 21, 2025 · 1 manufacturers, 1 listed presentations

As of Oct 21, 2025, the FDA lists Tranylcypromine Sulfate Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Tranylcypromine Sulfate Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Parnate, Tablet, 10 mg (NDC 0591-5590-01)
NDC 0591-5590-01
Teva Pharmaceuticals USA, Inc. Not specified Supply is expected to be depleted by 12/31/2025.

Related medications in shortage

Other Psychiatry medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Tranylcypromine Sulfate Tablet (FDA data as of Oct 21, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Tranylcypromine Sulfate Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Tranylcypromine Sulfate Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/tranylcypromine-sulfate-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).